Current and Future Immunotherapy Approaches for HCC: Evidence, Guidance, and Resources

This comprehensive program features expert hepatologist and medical oncologist perspectives on the evolving immunotherapy landscape for HCC with a focus on multidisciplinary best practices for managing your patients. Watch an on-demand Webcast from a live activity listen to podcasts and download the slides for discussion with your colleagues.

Share

Program Content

Activities

ICIs for HCC
Immunotherapy for HCC: Current Evidence and Future Directions
Congratulations: You achieved a completion on 04/09/2022
View Activity
ICIs for HCC: Update
Immunotherapy Approaches for HCC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: June 21, 2021

Expires: June 20, 2022

View Activity

Activities

ICIs for HCC
Current and Future Immunotherapy Approaches for HCC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 09, 2020

Expires: September 08, 2021

View Activity
<i>EP</i>: ICIs for HCC
ExpressPoints: Current and Future Immunotherapy Approaches for HCC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 14, 2020

Expires: September 13, 2021

View Activity
ICIs for HCC: Update
Immunotherapy for HCC: Evidence, Guidance, and Resources for the Multidisciplinary Care Team
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 30, 2021

Expires: April 29, 2022

View Activity

Activities

ICIs for HCC: Q&A 1
Experts Answer Clinician Questions on Immunotherapy for Advanced HCC: Podcast Pearls
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: January 21, 2021

Expires: January 20, 2022

View Activity
ICIs for HCC: Overview
An Expert Overview of Immunotherapy for Advanced HCC: Podcast Pearls
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: January 22, 2021

Expires: January 21, 2022

View Activity
ICIs for HCC: Cases
Immunotherapy for Advanced HCC: Case Series Podcast Pearls
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 17, 2021

Expires: May 16, 2022

View Activity
ICIs for HCC: Q&A 2
Current Immunotherapy Options for Advanced HCC and Expert Answers to Clinician Questions: Podcast Pearls
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 29, 2021

Expires: June 28, 2022

View Activity

Activities

ICIs for HCC: Q&A 1
Immunotherapy for Advanced HCC: Experts Answer Clinician Questions
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2020

Expires: December 09, 2021

View Activity
ICIs for HCC: Overview
An Expert Overview of Immunotherapy for Advanced HCC
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: January 19, 2021

Expires: January 18, 2022

View Activity
ICIs for HCC: Cases
Immunotherapy for Advanced HCC: Case Series
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: May 17, 2021

Expires: May 16, 2022

View Activity
ICIs for HCC: Q&A 2
Immunotherapy for Advanced HCC: Current Options and Expert Answers to Clinician Questions
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: June 29, 2021

Expires: June 28, 2022

View Activity

Faculty

cover img faculity

Lipika Goyal, MD

Assistant Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Harvard Medical School
Attending Physician
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

cover img faculity

David Kaplan, MD, MSc

Assistant Professor of Medicine
Division of Gastroenterology
University of Pennsylvania Perelman School of Medicine
Director of Hepatology
Gastroenterology Section
Philadelphia VA Medical Center
Philadelphia, Pennsylvania

cover img faculity

Thomas B. Karasic, MD

Assistant Professor of Medicine
Physician Leader, Developmental Therapeutics
Division of Hematology-Oncology
University of Pennsylvania
Philadelphia, Pennsylvania

cover img faculity

Amit G. Singal, MD, MS

Chief of Hepatology
Medical Director
, Liver Tumor Program
Professor, Department of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Genentech, a member of the Roche Group